ACTIVE

Perrigo Capital

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result11,1 M €-31,7 %over 1 year

Revenue2,2 M €+0,8 %over 1 year

Equity565,9 M €-21,6 %over 1 year

Workforce21,9 ETP-3,5 %over 1 year

Identity

Source · BCE/KBO

Perrigo Capital is a Public limited company incorporated in 1987. Its main activity is: Wholesale of coffee, tea, cocoa and spices. Its registered office is in Gent. It employs on average 21,9 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0430.784.027
Incorporation: 25/03/1987
Legal form: Public limited company
Registered office: Gaston Crommenlaan 6 box 606
9050 Gent · FlandreSee on map
Contributed capital: 522 072 515,00 €
Latest accounts: 31/12/2025
Average workforce: 21,9 ETP

Activities (NACE)

46370Wholesale of coffee, tea, cocoa and spices· main 46370Wholesale of coffee, tea, cocoa and spices 51370Air transport 64200Activities of holding companies 64210Activities of holding companies 74151Specialised design activities+3

Joint committees (2)

Signals

ProfitableSolid equityPositive cashflowHealthy social debtsHigh revenue

Financials

Source · NBB, 21 filings

Trend over 18 financial years

	2025		2023		2022		2021		2020
Income statement
Revenue	2,2 M €	+0.8%	2,2 M €	+12.3%	2 M €	-54.8%	4,3 M €	+16.9%	3,7 M €
EBITDA	-929,9 k €	-28.2%	-725,1 k €	-69.8%	-427,1 k €	-5.5%	-404,9 k €	+93.2%	-5,9 M €
Operating result	-929,9 k €	-28.2%	-725,1 k €	-69.8%	-427,1 k €	-5.5%	-404,9 k €	+93.2%	-5,9 M €
Net result	11,1 M €	-31.7%	16,3 M €	+83.1%	8,9 M €	+15.1%	7,7 M €	+116%	-49,7 M €
Balance sheet
Equity	565,9 M €	-21.6%	721,5 M €	+2.3%	705,2 M €	+1.3%	696,3 M €	+1.1%	688,6 M €
Total assets	1,6 Md €	+5.4%	1,5 Md €	-27.5%	2,1 Md €	+62.6%	1,3 Md €	-4.6%	1,3 Md €
Cash	66,8 M €	-51.4%	137,3 M €	+102%	68,1 M €	+76.7%	38,5 M €	+79.0%	21,5 M €
Debts	1 Md €	+30.5%	775,2 M €	-42.9%	1,4 Md €	+137%	572,5 M €	-10.7%	641,4 M €
Other
Workforce	21,9 ETP	-3.5%	22,7 ETP	+13.5%	20,0 ETP	+6.4%	18,8 ETP	+88.0%	10,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 M€ and 1.000 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 16 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Jonas Dhaenens	Director22/05/2026 → 13/05/2032
Sonia Hollies	Director04/03/2024 → 04/03/2030
Magali Verbraeken	Director23/01/2023 → 23/01/2029
Anja van Winsberghe	Director17/05/2021 → 13/05/2027

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Gianluca Parola	Director29/07/2021 → 2022 accounts
Bob de Weyn	Director08/01/2021 → 2023 accounts

Other companies at this address

Gaston Crommenlaan 6 9050 Gent

Company	CBE no.
BRAVX● Active	0834.939.871
LIGHTHOUSE INTELLIGENCE● Active	0676.420.293
Oce-Bio● Active	0442.861.022
omega pharma group● Active	0837.048.632
OMEGA PHARMA INNOVATION & DEVELOPMENT● Active	0884.084.724
OMEGA PHARMA INTERNATIONAL● Active	0807.596.363
OMEGA PHARMA TRADING● Active	0417.092.080
Perrigo Belgium● Active	0417.132.860
Perrigo Europe Invest● Active	0439.658.834
Perrigo Holding● Active	0431.676.229
Silverfin● Active	0524.802.662
TM BRAVO4 CIVIEL● Active	0787.232.501
TM BRAVO-4 KOEPEL-EPC● Active	1008.974.796
TM Goedingebrug● Active	1039.143.281
TM Nieuwe Waasmunsterbrug over Durme● Active	1035.016.328

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	06/07/2026	18/06/2025	22/05/2024	25/05/2023	17/06/2022	14/06/2021
General meeting	29/06/2026	20/05/2025	13/05/2024	11/05/2023	12/05/2022	17/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	29/06/2026	06/07/2026	Dutch	PDF
Full model	31/12/2024	20/05/2025	18/06/2025	Dutch	PDF
Full model	31/12/2023	13/05/2024	22/05/2024	Dutch	PDF
Full model	31/12/2022	11/05/2023	25/05/2023	Dutch	PDF
Full model	31/12/2021	12/05/2022	17/06/2022	Dutch	PDF
Full model	31/12/2020	17/05/2021	14/06/2021	Dutch	PDF
Full model	31/12/2019	14/05/2020	12/06/2020	Dutch	PDF
Full modelCorrection	31/12/2018	16/07/2019	06/09/2019	Dutch	PDF
Full model	31/12/2018	09/05/2019	24/05/2019	Dutch	PDF
Full model	31/12/2017	25/05/2018	30/05/2018	Dutch	PDF
Full model	31/12/2016	16/06/2017	06/07/2017	Dutch	PDF
Full model	31/12/2015	20/06/2016	08/07/2016	Dutch	PDF
Full model	31/12/2014	19/06/2015	23/06/2015	Dutch	PDF
Full model	31/12/2013	30/05/2014	23/06/2014	Dutch	PDF
Full model	31/12/2012	31/05/2013	25/06/2013	Dutch	PDF
Full model	31/12/2011	25/05/2012	14/06/2012	Dutch	PDF
Full model	31/12/2010	27/05/2011	30/05/2011	Dutch	PDF
Full model	31/12/2009	28/05/2010	16/06/2010	Dutch	PDF
Full model	31/12/2008	29/05/2009	08/06/2009	Dutch	PDF
Full model	31/12/2007	30/05/2008	27/06/2008	Dutch	PDF
Full model	31/12/2006	25/05/2007	22/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 M€ and 1.000 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 16 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Jonas Dhaenens	Director22/05/2026 → 13/05/2032
Sonia Hollies	Director04/03/2024 → 04/03/2030
Magali Verbraeken	Director23/01/2023 → 23/01/2029
Anja van Winsberghe	Director17/05/2021 → 13/05/2027

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Gianluca Parola	Director29/07/2021 → 2022 accounts
Bob de Weyn	Director08/01/2021 → 2023 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates08/06/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/12/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/06/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates15/03/2024
ONTSLAGEN - BENOEMINGEN
PDF
Registered office24/11/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - DIVERSEN - MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN
PDF
Mandates01/03/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/01/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/09/2021
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings18 filings

Mandates

Jonas Dhaenens

Sonia Hollies

Magali Verbraeken

Anja van Winsberghe

Gianluca Parola

Bob de Weyn

Ignace Bogaert

Excito

O' Sullivan Patrick

BRANDRACER

CALISCO

Foxfin

Show the 8 other mandates

1987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029203020312032

Perrigo CapitalOMEGA PHARMA CAPITAL

Gaston Crommenlaan 6 bte 606, 9050 Ledeberg (Gent)Venecoweg 26, 9810 Nazareth-De Pinte

Director

Managing directorDirector

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Gaston Crommenlaan 6 bte 606, 9050 Ledeberg (Gent)Current	accounts 2023 → 2025	Accounts 2025 · 2026-00275969
Venecoweg 26, 9810 Nazareth-De Pinte	accounts 2021 → 2022	Accounts 2022 · 2023-00100284

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Perrigo CapitalCurrent	accounts 2023 → 2025	Accounts 2025 · 2026-00275969
OMEGA PHARMA CAPITAL	accounts 2006 → 2022	Accounts 2022 · 2023-00100284

Events

22/05/2026
nominationJonas Dhaenens · bestuurder
2025
Annual accounts 202511,1 M €↓
20/05/2025
nominationBDO Bedrijfsrevisoren BV · commissaris
13/05/2024
reconductionPaul Eelen · commissaris
04/03/2024
nominationSonia Hollies · bestuurder
2023
Annual accounts 202316,3 M €↑
2023
Name changePerrigo Capital
23/01/2023
nominationMagali Verbraeken · bestuurder
2022
Annual accounts 20228,9 M €↑
2021
Annual accounts 20217,7 M €↑
2020
Annual accounts 2020-49,7 M €↓
2019
Annual accounts 20199,4 M €↓
2018
Annual accounts 201810 M €↑
2017
Annual accounts 2017-5,3 M €↓
2016
Annual accounts 201614,9 M €↑
2015
Annual accounts 201514,3 M €↑
2014
Annual accounts 20146,2 M €↑
2013
Annual accounts 20135 M €↓
2012
Annual accounts 20128,5 M €↓
2011
Annual accounts 201110,3 M €↑
2010
Annual accounts 20104,4 M €↓
2009
Annual accounts 20095,8 M €↓
2007
Annual accounts 200710,7 M €↑
2006
Annual accounts 20066,4 M €
25/03/1987
IncorporationPublic limited company

Perrigo Capital

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events